http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110917425-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_356b7dc49a7a2e0564a3e4d9c7e17e8a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3681 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3683 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-0272 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-02 |
| filingDate | 2018-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02c279e39d6bfc0257c669caf89ef744 |
| publicationDate | 2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110917425-A |
| titleOfInvention | Treatment method and device capable of killing virus in isolated blood |
| abstract | The invention discloses a treatment method capable of killing viruses in isolated blood, which is characterized in that a lead seal box integrating the functions of X-ray irradiation, halogen lamp light irradiation and X-ray radiation shielding and internally provided with an irradiation cavity is arranged, so that an isolated blood sample internally added with methylene blue photosensitizer can simultaneously receive the X-ray irradiation and the halogen lamp light irradiation in the irradiation cavity to kill the viruses, bacteria and lymphocytes with immunological activity in the blood. The invention also discloses a device capable of killing the virus in the isolated blood. The invention concentrates the two processing technologies of single step in the prior art into one lead box body to be simultaneously completed, thereby greatly compressing the processing space, shortening the processing time, improving the processing quality and the working efficiency, simplifying the equipment, omitting the repeated package, the round-trip transportation and the errors among sample groups of the blood samples, and being beneficial to ensuring the consistency of the processing result, thereby effectively overcoming the defects in the prior art of single step in-vitro blood processing. |
| priorityDate | 2018-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476681 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4139 |
Total number of triples: 16.